Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment-Reference-Cited by-同舟云学术

Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment

Published:2021-08 Issue: Volume:302 Page:114022
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Scheffler Freda^ORCID,Phahladira Lebogang^ORCID,Luckhoff Hilmar,du Plessis Stefan,Asmal Laila^ORCID,Kilian Sanja,Forti Marta Di,Murray Robin,Emsley Robin

Funder

SAMRC

SAMRC RCD

New Partnership for Africa's Development

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference41 articles.

1. Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program;Abdel-Baki;Psychiatry Res.,2017

2. Assessing depression in schizophrenia: the calgary depression scale;Addington;Br. J. Psychiatry,1993

3. Diagnostic and Statistical Manual of Mental Dis- orders;Association,1994

4. Remission in schizophrenia: proposed criteria and rationale for consensus;Andreasen;Am. J. Psychiatry,2005

5. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study);Baeza;Schizophr. Res.,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder;Schizophrenia Bulletin;2024-06-20

2. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study;Schizophrenia Bulletin;2024-03-26

3. Relapse in schizophrenia: The role of factors other than non‐adherence to treatment;Early Intervention in Psychiatry;2024-02-06

4. Cannabidiol Nanosystems as a Potential Therapy Targeting Essential Regulators in Metabolic Syndrome;2024

5. Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals;eClinicalMedicine;2023-10